21 to 30 of 2,559 Results
Adobe PDF - 220.6 KB -
MD5: 09b0b7b7245dcb116eb15df62fdef98d
Suppl. Table 5. Meta-regression for trials investigating hypothyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 257.8 KB -
MD5: d6acaa2141ff4cf50ded0d6820579aea
Suppl. Table 4. Frequencies of various parameters in included trials, n= 80 trials. |
MS Excel Spreadsheet - 116.7 KB -
MD5: 7b97c14d958dffb9cb3347b48fd10fba
Suppl. Table 3. Study characteristics of randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. NSCLC, Non-small cell lung cancer; LD-SCLC, Limited... |
Adobe PDF - 363.9 KB -
MD5: 7c1640658f8d06736e3dad712a927841
Suppl. Table 2. Search strategies for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. |
Adobe PDF - 219.2 KB -
MD5: f9d8e1df71b9731cc42906df4abab368
Suppl. Table 12. Trim-and-fill results for trials investigating insulin-dependent diabetes mellitus grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 216.4 KB -
MD5: 37c1389d7ef9b12de77e87300a627604
Suppl. Table 11. Trim-and-fill results for trials investigating insulin-dependent diabetes mellitus any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 219.1 KB -
MD5: b0d44cc6d4f377511600f93c84adb67c
Suppl. Table 10. Trim-and-fill results for trials investigating adrenal insufficiency grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 625.1 KB -
MD5: 591d49eda306f69d5fd24a059d714ccc
Suppl. Table 1. Checklist according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monoth... |
Adobe PDF - 123.5 KB -
MD5: bca376270d42ef0d17b56dc422bd4937
Suppl. Fig. 9. Forest plot for subgroups of ICI types trials investigating hyperthyroidism grade 3-5 under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |
Adobe PDF - 80.8 KB -
MD5: 57e8d84f42b25d9f50320342f7c3ccee
Suppl. Fig. 8. Forest plot for cumulative meta-analysis for trials investigating hyperthyroidism any grade under immune checkpoint inhibitor therapy in solid tumors, n= 80 trials. |